Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$7.06 - $23.63 $153,639 - $514,236
21,762 New
21,762 $181,000
Q1 2020

Jan 08, 2024

SELL
$12.98 - $30.25 $506,220 - $1.18 Million
-39,000 Closed
0 $0
Q3 2019

Jan 08, 2024

BUY
$20.88 - $25.66 $430,128 - $528,596
20,600 Added 111.96%
39,000 $8.51 Million
Q2 2019

Jan 08, 2024

BUY
$20.52 - $26.45 $377,568 - $486,680
18,400 New
18,400 $9.88 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.33B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.